Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jill Hagenkord, Robert Daber, Qingson Zhu


23andMe has appointed Jill Hagenkord to chief medical officer. Hagenkord joins 23andMe from InVitae where she served as medical director. Prior to that, she was chief medical officer and senior vice president at Complete Genomics. She was also founder and chief medical officer for iKaryos Diagnostics, associate professor of pathology at Creighton University School of Medicine, director of molecular pathology and clinical genomics at Creighton Medical Laboratories, and pathologist at Deltagen. She is a board-certified medical genetic pathologist.

Bio-Reference Laboratories has appointed Robert Daber to director of research and development and director of cancer genetics. Daber was previously the technical director of clinical genetics at the University of Pennsylvania, where he helped develop next-generation sequencing-based diagnostic cancer tests. Prior to that, he was a post-doctoral fellow at the Children's Hospital of Philadelphia.

Insilico Medicine, which is using genomics to discover new therapies targeted age-related diseases, has appointed cancer genomics expert Qingson Zhu to chief operating officer. Zhu spent seven years as a postdoctoral research fellow at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University where he worked on biomarker identification and drug development using microarray and next-generation sequencing technologies.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.